Lidocaine-Propitocain Cream, A Form of Eutectic Mixture of Local Anesthetics (EMLA), Is an Effective Pain Relief on Vascular Access Intervention Therapy in Hemodialysis Patients: A Placebo-Controlled, Double-Blind, Crossover Study

Lidocaine-Propitocain Cream, A Form of Eutectic Mixture of Local Anesthetics (EMLA), Is an Effective Pain Relief on Vascular Access Intervention Therapy in Hemodialysis Patients: A Placebo-Controlled, Double-Blind, Crossover Study - Lidocaine-Propitocain Cream, A Form of Eutectic Mixture of Local Anesthetics (EMLA), Is an Effective Pain Relief on Vascular Access Intervention Therapy in Hemodialysis Patients: A Placebo-Controlled, Double-Blind, Crossover Study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000035001

Enrollment

Registered

2018-11-27

Start date

2017-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vascular access trouble

Interventions

topical Lidocaine-Propitocain cream, a form of eutectic mixture of local anesthetics (EMLA)application placebo

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 20 years old and over

Exclusion criteria

Exclusion criteria: AVG

Design outcomes

Primary

Measure	Time frame
the degree of pain on VAIVT scored by visual analog scale (VAS)	—

Countries

Japan

Contacts

Public ContactOka Hideaki

Matsuyama Red Cross Hospital Kidney Center

seishiaihara@matsuyama.jrc.or.jp0899241111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026